Intrexon Corporation (Public - NYSE: XON) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.
Chubut Province Offers Services to China's Unregulated Fishing Fleet Argentina
The Chubut government offered the IUU (Illegal, Unreported and Unregulated) fishing fleet of China supplies in the ports of the province, according to what was revealed after a meeting between Governo...
Sustainable Tasmanian Sardine Fishery a Step Closer Australia
The Tasmanian Government is pleased to announce promising developments toward the establishment of a sustainable sardine fishery, an initiative that would bolster job creation, open new economic oppor...
Oman’s Fisheries Sector Adds $374M to GDP, Achieves 13% Growth Oman
Oman’s fisheries sector continues its impressive trajectory of growth, contributing $374 million to the nation’s GDP and recording a 13% increase in fish production from January to July 20...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER
Intrexon Corporation
Shareholder/Associate at:
Print
